Nadine Beauger, Chief Executive Officer of IRICoR, participates in the MEDTEQ’s 6th Annual Forum to present the innovative business model of IRICoR.
As Université de Montréal’s drug discovery and project maturation cluster, IRICoR brings together a team of expert working to accelerate the discovery of drugs. In recent years, new alliances between academia and the pharmaceutical industry have emerged to transform research efforts into innovative therapeutic solutions.
IRICoR is at the forefront of these new partnerships that enable science to create direct and real impacts for the benefit of Canadians.
For more information on the program
